跳轉至內容
Merck
  • Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol.

Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol.

Fertility and sterility (2014-02-19)
Human Mousavi Fatemi, Biljana Popovic-Todorovic, Peter Humaidan, Shahar Kol, Manish Banker, Paul Devroey, Juan Antonio García-Velasco
摘要

To report two cases with GnRH agonist triggering and a freeze-all approach in a GnRH antagonist protocol resulting in the development of severe ovarian hyperstimulation syndrome (OHSS), requiring hospitalization and peritoneal drainage. Two case reports. A tertiary referral center and an obstetrics and gynecology department of a hospital. Case 1 and case 2: severe OHSS with abdominal distension, ascites development, and hemoconcentration. Case 1 and case 2: diagnosed by clinical, hematologic, and ultrasound findings. Hospitalization, IV infusion, and peritoneal drainage. Symptomatic treatment and prevention of further complication. Complete recovery. Two cases of severe OHSS after GnRH agonist trigger in a GnRH antagonist protocol without the administration of any hCG for luteal-phase support. Clinicians have to be aware that even the sequential approach to ovarian stimulation with a freeze-all attitude does not completely eliminate OHSS in all patients.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
卵泡刺激素 来源于人类脑垂体, ~7,000 IU/mg (powder)
Gonadorelin, European Pharmacopoeia (EP) Reference Standard